News

Filter

Current filters:

Markets & Marketing

1 to 9 of 2485 results

Ukraine drugmakers want government to revise state tendering decision

27-03-2015

Leading Ukrainian pharmaceutical producers have called on the national government to revise the earlier…

Markets & MarketingPharmaceuticalPoliticsUkraine

Slow growth forecast for Germany’s pharma market

27-03-2015

While Germany is the leading pharmaceutical market in Europe, valued at $58.6 billion in 2014, the sector…

GermanyMarkets & MarketingPharmaceuticalPricingRegulation

Anti-trust regulator orders Bayer Korea to sell oral contraceptive business acquired through Merck deal

26-03-2015

South Korea's anti-trust regulator this week ordered the local subsidiary of German pharma major Bayer…

BayerLegalMarkets & MarketingPharmaceuticalReproductiveSouth Korea

Green Cross and Nanolek enter strategic partnership to commercialize biologics in Russia

Green Cross and Nanolek enter strategic partnership to commercialize biologics in Russia

26-03-2015

South Korean biopharma company Green Cross and Russian drugmaker Nanolek have entered into a strategic…

BiotechnologyGreen CrossLicensingMarkets & MarketingNanolekRussia

Sepsis-specific treatment market set to grow to $354 million in 2021; report

26-03-2015

Following the first sepsis-specific product launch in 2016, the treatment market will expand at a compound…

Antibiotics and Infectious diseasesART-123Asahi Kasei PharmaEli LillyEuropeMarkets & MarketingPharmaceuticalUSAXigris

Global smart pills market to be worth $8.98 billion by 2024

25-03-2015

According to a new market research report, "Smart Pills Market by Application (Capsule Endoscopy, Drug…

GlobalMarkets & MarketingPharmaceutical

Lack of data and data management hindering hepatitis C progress in England, says IMS Health

Lack of data and data management hindering hepatitis C progress in England, says IMS Health

24-03-2015

Limited data and the disparate nature of the datasets that are available have been challenges to measuring…

Markets & MarketingNephrology and HepatologyPharmaceuticalSocial IssuesUK

Confluence Pharma inks deal with AOP Orphan for Fragile X syndrome drug

23-03-2015

Privately-held USA-based Confluence Pharmaceuticals and Austria’s AOP Orphan Pharmaceuticals have signed…

AOP Orphan PharmaceuticalsBiotechnologyConfluence PharmaceuticalsEuropeLicensingMarkets & MarketingRare diseases

1 to 9 of 2485 results

Back to top